AF
Andrew Fein HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
109
Avg Return
Past Year
Past Year
43%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
92.9%
Neutral
7.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $25 | – | 1 | +210% |
0
%
| 6 Aug ‘25 8 months ago |
|
|
|
Buy
Assumed
| $23 |
254%
upside
| 1 | -1.4% |
0
%
| 30 Jun ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $32 |
46%
upside
| 2 | -1.9% |
0
%
| 26 Jun ‘25 10 months ago |
|
|
|
Buy
Maintained
| $8 |
419%
upside
| 2 | +123% |
0
%
| 29 May ‘25 11 months ago |
|
|
|
Neutral
Downgraded
| $8 |
1%
downside
| 1 | +274% |
–
| 27 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $35 |
3%
upside
| 2 | +141% |
0
%
| 14 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $14 |
138%
upside
| 1 | +235% |
0
%
| 14 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $75 |
65%
upside
| 2 | +69% |
0
%
| 12 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $68 |
7%
downside
| 3 | +51% |
0
%
| 12 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $38 |
108%
upside
| 2 | +29% |
0
%
| 9 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $25 |
117%
upside
| 2 | +7.5% |
0
%
| 8 May ‘25 11 months ago |
|
|
|
Buy
Maintained
| $32 |
61%
upside
| 1 | +51% |
0
%
| 7 May ‘25 11 months ago |
|
|
|
Buy
Reiterated
| $135 |
4%
upside
| 1 | +30% |
0
%
| 2 May ‘25 1 year ago |
|
|
|
Buy
Maintained
| $12 |
323%
upside
| 2 | +39% |
0
%
| 1 May ‘25 1 year ago |
|
|
|
Buy
Reiterated
| $8 |
8%
upside
| 1 | +210% |
0
%
| 28 Apr ‘25 1 year ago |
|